DXCM  valuation analysis

Name: DexCom Inc
Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. (more)
Industry: Medical Devices
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 28, 2022
Market cap: $27.29B (257th)
Sales(TTM): $2.57B (722nd)
Earnings(TTM): $211.00M (773rd)

FFER: 4.37 (why)
Actual price: $281.32
FFEThis is DexCom Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $64.33
Quantile: DXCM is very expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
DexCom Inc
"Medical Devices" industry
Sales / MarketCap
DexCom Inc
"Medical Devices" industry
Book / MarketCap
DexCom Inc
"Medical Devices" industry
Equity / Assets
DexCom Inc
"Medical Devices" industry